Dakshidin Corporation (DKSC), Signs LOI for Worldwide Exclusive Licensing Agreement
January 15, 2019 09:56 ET
|
Dakshidin Corporation
LAS VEGAS, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Dakshidin Corporation (DKSC) announced today that it had signed a Letter of Intent for a worldwide exclusive licensing agreement with GenBio, a...
CURE Pharmaceutical Expands Distribution of CUREfilm Technology with First Licensing Agreement
September 05, 2018 08:57 ET
|
CURE Pharmaceutical
LOS ANGELES, Sept. 05, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), (“CURE”), an innovative drug delivery and development company, today announced that it entered into a multi-year...
Mission Ready Provides Unifire and Recent Progress Update, Contemplates Streamlined Licensing Arrangement with Foreign Military Distributor in Advance of Anticipated Orders
August 07, 2018 17:24 ET
|
Mission Ready Solutions Inc.
VANCOUVER, British Columbia, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Mission Ready Solutions Inc. (“Mission Ready” or the “Company”) (TSXV:MRS) is pleased to provide an update on the Company’s forward...
Summit Enters Into Licence and Commercialisation Agreement With Eurofarma for Latin American Rights to Ridinilazole, Summit’s Precision Antibiotic in Development for the Treatment of CDI
December 21, 2017 02:00 ET
|
Summit Therapeutics plc
Summit to receive $2.5 million upfront paymentUp to $25 million in development, regulatory, pricing and initial sales milestonesSummit retains commercial rights to ridinilazole in rest of the world ...
Assembly Biosciences Announces the Closing and Early Termination of Hart-Scott-Rodino Waiting Period for License of Microbiome Gastrointestinal Development Programs to Allergan
February 21, 2017 07:05 ET
|
Assembly Biosciences, Inc.
INDIANAPOLIS, Feb. 21, 2017 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development Programs
January 09, 2017 08:00 ET
|
Assembly Biosciences, Inc.
-- Expands Allergan’s Innovative GI Pipeline with ABI-M201 and ABI-M301, Preclinical Compounds Targeting Ulcerative Colitis and Crohn’s Disease, as well as Future Compounds for Irritable Bowel...
Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200
June 09, 2015 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 9, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP) announced today that it has entered into a sales and distribution licensing...
Soul and Vibe Licenses Its Games to Tanjarine
July 24, 2014 07:00 ET
|
Soul and Vibe Interactive Inc.
MINNEAPOLIS, July 24, 2014 (GLOBE NEWSWIRE) -- Soul and Vibe Interactive Inc. (OTCQB:SOUL), "The Company," a video and computer games company, today announced that it has entered into a license...
Tauriga Sciences Inc. Signs License Agreement With Targeted Medical Pharma Inc.
July 16, 2014 15:30 ET
|
Tauriga Sciences Inc
LOS ANGELES, July 16, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or the "Company"), a diversified life sciences company, announced today it has signed a non-exclusive...
Evotec Grants Exclusive Rights on EVT 401 in China to Conba Pharmaceutical
May 02, 2012 02:05 ET
|
Evotec AG
License Granted to One of the Largest Pharmaceutical Companies in China
Development of Evotec Proprietary Compound EVT 401 Intended for Inflammatory Diseases
Upfront, Approx. € 60...